MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling

por Zhou, Xin, Luo, Jianzhu, Xie, Haixiang, Wei, Zhongliu, Li, Tianman, Liu, Junqi, Liao, Xiwen, Zhu, Guangzhi, Peng, Tao
Publicado 2022

RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma

por Wei, Yongguang, Lan, Chenlu, Wang, Xiangkun, Zhou, Xin, Liao, Xiwen, Huang, Huasheng, Wei, Zhongliu, Li, Tianman, Peng, Tao, Zhu, Guangzhi
Publicado 2023

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma

por Nong, Jusen, Yang, Kejian, Li, Tianman, Lan, Chenlu, Zhou, Xin, Liu, Junqi, Xie, Haixiang, Luo, Jianzhu, Liao, Xiwen, Zhu, Guangzhi, Peng, Tao
Publicado 2023